Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

FibroGen Cash on Hand 2013-2025 | FGEN

FibroGen cash on hand from 2013 to 2025. Cash on hand can be defined as cash deposits at financial institutions that can immediately be withdrawn at any time, and investments maturing in one year or less that are highly liquid and therefore regarded as cash equivalents and reported with or near cash line items.
  
FibroGen Annual Cash on Hand
(Millions of US $)
2024 $50
2023 $203
2022 $422
2021 $405
2020 $687
2019 $534
2018 $621
2017 $736
2016 $253
2015 $181
2014 $180
2013 $123
2012 $40
FibroGen Quarterly Cash on Hand
(Millions of US $)
2025-03-31 $34
2024-12-31 $50
2024-09-30 $131
2024-06-30 $141
2024-03-31 $178
2023-12-31 $203
2023-09-30 $251
2023-06-30 $336
2023-03-31 $356
2022-12-31 $422
2022-09-30 $409
2022-06-30 $438
2022-03-31 $428
2021-12-31 $405
2021-09-30 $486
2021-06-30 $507
2021-03-31 $544
2020-12-31 $687
2020-09-30 $688
2020-06-30 $686
2020-03-31 $535
2019-12-31 $534
2019-09-30 $629
2019-06-30 $661
2019-03-31 $565
2018-12-31 $621
2018-09-30 $653
2018-06-30 $672
2018-03-31 $704
2017-12-31 $736
2017-09-30 $730
2017-06-30 $359
2017-03-31 $243
2016-12-31 $253
2016-09-30 $242
2016-06-30 $231
2016-03-31 $173
2015-12-31 $181
2015-09-30 $222
2015-06-30 $249
2015-03-31 $143
2014-12-31 $180
2014-09-30
2014-06-30
2014-03-31
2013-12-31 $123
2012-12-31 $40
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.021B $0.030B
FibroGen, Inc. is a research-based biotechnology company. It is focused on the discovery, development, and commercialization of therapeutic agents for treatment of anemia, fibrosis, cancer, and other serious unmet medical needs. The Company develops Roxadustat that is in Phase III clinical development for the treatment of anemia in chronic kidney disease; and FG-3019 which is in Phase II clinical development for the treatment of idiopathic pulmonary fibrosis, pancreatic cancer, and liver fibrosis. FibroGen, Inc. is headquartered in San Francisco, California.
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) Japan $85.797B 32.19
Zoetis (ZTS) United States $69.430B 25.91
Takeda Pharmaceutical (TAK) Japan $49.193B 9.78
Daiichi Sankyo, - (DSNKY) Japan $43.987B 22.54
BeOne Medicines - (ONC) Cayman Islands $26.531B 0.00
Sandoz Group AG (SDZNY) Switzerland $24.053B 0.00
Merck (MKKGY) Germany $16.763B 12.28
Summit Therapeutics (SMMT) United States $15.804B 0.00
Shionogi (SGIOY) Japan $15.161B 15.19
United Therapeutics (UTHR) United States $12.961B 11.47
Neurocrine Biosciences (NBIX) United States $12.439B 42.61
Orion OYJ (ORINY) Finland $10.495B 28.38
IPSEN (IPSEY) France $10.108B 0.00
Corcept Therapeutics (CORT) United States $7.784B 63.28
Stevanato Group S.p.A (STVN) Italy $7.398B 45.24
Madrigal Pharmaceuticals (MDGL) United States $6.720B 0.00
Ionis Pharmaceuticals (IONS) United States $6.288B 0.00
Grifols, S.A (GRFS) Spain $6.216B 0.00
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $6.153B 0.00
Ono Pharmaceutical (OPHLF) Japan $4.382B 13.33
Soleno Therapeutics (SLNO) United States $4.222B 0.00
Hypermarcas (HYPMY) Brazil $3.059B 20.12
Crinetics Pharmaceuticals (CRNX) United States $2.693B 0.00
Catalyst Pharmaceuticals (CPRX) United States $2.647B 9.27
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.536B 13.71
NewAmsterdam Pharma (NAMS) Netherlands $2.033B 0.00
BioCryst Pharmaceuticals (BCRX) United States $1.875B 0.00
Centessa Pharmaceuticals (CNTA) United Kingdom $1.755B 0.00
ARS Pharmaceuticals (SPRY) United States $1.714B 0.00
Endo (NDOI) United States $1.602B 0.00
Evotec AG (EVO) Germany $1.491B 0.00
Ocular Therapeutix (OCUL) United States $1.478B 0.00
Guardian Pharmacy Services (GRDN) United States $1.349B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.144B 22.89
Harrow (HROW) United States $1.120B 0.00
Dyne Therapeutics (DYN) United States $1.082B 0.00
Verve Therapeutics (VERV) United States $1.001B 0.00
Enliven Therapeutics (ELVN) United States $0.984B 0.00
Akebia Therapeutics (AKBA) United States $0.956B 0.00
Collegium Pharmaceutical (COLL) United States $0.950B 5.12
Ardelyx (ARDX) United States $0.938B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.856B 0.00
Elite Pharmaceuticals (ELTP) United States $0.782B 0.00
Cronos Group (CRON) Canada $0.737B 0.00
Xeris Biopharma Holdings (XERS) United States $0.730B 0.00
Relay Therapeutics (RLAY) United States $0.593B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.571B 0.00
USANA Health Sciences (USNA) United States $0.569B 12.36
KalVista Pharmaceuticals (KALV) United States $0.562B 0.00
Xencor (XNCR) United States $0.559B 0.00
Theravance Biopharma (TBPH) United States $0.552B 0.00
Bioventus (BVS) United States $0.544B 13.79
Zevra Therapeutics (ZVRA) United States $0.482B 0.00
AleAnna (ANNA) United States $0.480B 0.00
Siga Technologies (SIGA) United States $0.466B 9.73
Organogenesis (ORGO) United States $0.464B 0.00
Oruka Therapeutics (ORKA) United States $0.420B 0.00
Tourmaline Bio (TRML) United States $0.411B 0.00
Savara (SVRA) United States $0.394B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.335B 9.05
Aquestive Therapeutics (AQST) United States $0.329B 0.00
Nektar Therapeutics (NKTR) United States $0.321B 0.00
Heron Therapeutics (HRTX) United States $0.316B 0.00
Altimmune (ALT) United States $0.314B 0.00
Liminatus Pharma (LIMN) United States $0.290B 0.00
Nature's Sunshine Products (NATR) United States $0.273B 25.07
Tonix Pharmaceuticals Holding (TNXP) United States $0.265B 0.00
Aldeyra Therapeutics (ALDX) United States $0.229B 0.00
Nanobiotix S.A (NBTX) France $0.223B 0.00
OmniAb (OABI) United States $0.213B 0.00
MediWound (MDWD) Israel $0.209B 0.00
Esperion Therapeutics (ESPR) United States $0.195B 0.00
Larimar Therapeutics (LRMR) United States $0.185B 0.00
Profound Medical (PROF) Canada $0.177B 0.00
ProKidney (PROK) United States $0.173B 0.00
4D Molecular Therapeutics (FDMT) United States $0.172B 0.00
Journey Medical (DERM) United States $0.167B 0.00
Innate Pharma SA (IPHYF) France $0.163B 0.00
Aclaris Therapeutics (ACRS) United States $0.154B 0.00
Inhibikase Therapeutics (IKT) United States $0.145B 0.00
Avita Medical (RCEL) United States $0.140B 0.00
Galectin Therapeutics (GALT) United States $0.134B 0.00
Lexeo Therapeutics (LXEO) United States $0.133B 0.00
Lyell Immunopharma (LYEL) United States $0.131B 0.00
Korro Bio (KRRO) United States $0.117B 0.00
Protara Therapeutics (TARA) United States $0.117B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.116B 0.00
Cardiol Therapeutics (CRDL) Canada $0.112B 0.00
VAXART, INC (VXRT) United States $0.103B 0.00
Champions Oncology (CSBR) United States $0.102B 16.75
Nutriband (NTRB) United States $0.088B 0.00
Cassava Sciences (SAVA) United States $0.087B 0.00
Arch Biopartners (ACHFF) Canada $0.086B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.084B 0.00
Dominari Holdings (DOMH) United States $0.080B 0.00
Fractyl Health (GUTS) United States $0.079B 0.00
Achieve Life Sciences (ACHV) Canada $0.078B 0.00
Surrozen (SRZN) United States $0.077B 0.00
Vivani Medical (VANI) United States $0.076B 0.00
ESSA Pharma (EPIX) Canada $0.075B 0.00
Wellgistics Health (WGRX) United States $0.070B 0.00
Pyxis Oncology (PYXS) United States $0.068B 0.00
Inotiv (NOTV) United States $0.063B 0.00
Assertio Holdings (ASRT) United States $0.061B 0.00
Rafael Holdings (RFL) United States $0.061B 0.00
Unicycive Therapeutics (UNCY) United States $0.060B 0.00
Context Therapeutics (CNTX) United States $0.059B 0.00
Allergy Therapeutics (AGYTF) United Kingdom $0.059B 0.00
NRx Pharmaceuticals (NRXP) United States $0.056B 0.00
Metagenomi (MGX) United States $0.055B 0.00
PMV Pharmaceuticals (PMVP) United States $0.055B 0.00
Avalo Therapeutics (AVTX) United States $0.054B 0.00
Gain Therapeutics (GANX) United States $0.054B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.050B 37.22
Verrica Pharmaceuticals (VRCA) United States $0.049B 0.00
Century Therapeutics (IPSC) United States $0.048B 0.00
Prelude Therapeutics (PRLD) United States $0.046B 0.00
Mural Oncology (MURA) Ireland $0.043B 0.00
Iterum Therapeutics (ITRM) Ireland $0.040B 0.00
ElectroCore (ECOR) United States $0.039B 0.00
Acrivon Therapeutics (ACRV) United States $0.037B 0.00
Karyopharm Therapeutics (KPTI) United States $0.037B 0.00
Telomir Pharmaceuticals (TELO) United States $0.037B 0.00
Klotho Neurosciences (KLTO) United States $0.037B 0.00
PolyPid (PYPD) Israel $0.036B 0.00
Jupiter Neurosciences (JUNS) United States $0.034B 0.00
China SXT Pharmaceuticals (SXTC) China $0.027B 0.00
Enlivex Therapeutics (ENLV) Israel $0.026B 0.00
SCYNEXIS (SCYX) United States $0.026B 0.00
VYNE Therapeutics (VYNE) United States $0.025B 0.00
Tempest Therapeutics (TPST) United States $0.025B 0.00
Natural Alternatives (NAII) United States $0.020B 0.00
Relmada Therapeutics (RLMD) United States $0.020B 0.00
DURECT (DRRX) United States $0.020B 0.00
BioLineRx (BLRX) Israel $0.019B 0.00
Vivos Therapeutics (VVOS) United States $0.019B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.018B 0.00
Mannatech (MTEX) United States $0.018B 0.00
Plus Therapeutics (PSTV) United States $0.018B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.017B 0.00
BioVie (BIVI) United States $0.017B 0.00
Citius Pharmaceuticals (CTXR) United States $0.017B 0.00
Lipocine (LPCN) United States $0.017B 0.00
Carisma Therapeutics (CARM) United States $0.016B 0.00
ProPhase Labs (PRPH) United States $0.016B 0.00
CASI Pharmaceuticals (CASI) China $0.015B 0.00
Scienture Holdings (SCNX) United States $0.014B 0.00
Ernexa Therapeutics (ERNA) United States $0.014B 0.00
TherapeuticsMD (TXMD) United States $0.013B 0.00
Cosmos Health (COSM) United States $0.012B 0.00
Minerva Neurosciences (NERV) United States $0.012B 2.10
Lyra Therapeutics (LYRA) United States $0.012B 0.00
Ainos (AIMD) United States $0.012B 0.00
Phio Pharmaceuticals (PHIO) United States $0.011B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.010B 0.00
Addex Therapeutics (ADXN) Switzerland $0.010B 0.00
Talphera (TLPH) United States $0.009B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.009B 0.00
Traws Pharma (TRAW) United States $0.008B 0.00
Biomerica (BMRA) United States $0.008B 0.00
Alaunos Therapeutics (TCRT) United States $0.008B 0.00
Mangoceuticals (MGRX) United States $0.008B 0.00
Nuvilex (PMCB) United States $0.007B 0.00
TransCode Therapeutics (RNAZ) United States $0.007B 0.00
Incannex Healthcare (IXHL) Australia $0.006B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.006B 0.00
Xenetic Biosciences (XBIO) United States $0.006B 0.00
Indaptus Therapeutics (INDP) United States $0.006B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.005B 0.00
Aptorum Group (APM) United Kingdom $0.005B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.005B 0.00
Redhill Biopharma (RDHL) Israel $0.004B 0.00
SHINECO (SISI) China $0.004B 0.00
InMed Pharmaceuticals (INM) Canada $0.004B 0.00
Clearmind Medicine (CMND) Canada $0.004B 0.00
CERo Therapeutics Holdings (CERO) United States $0.004B 0.00
SciSparc (SPRC) Israel $0.003B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.003B 0.00
XORTX Therapeutics (XRTX) Canada $0.003B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.003B 0.00
PainReform (PRFX) Israel $0.003B 0.00
Aditxt (ADTX) United States $0.003B 0.00
Jaguar Animal Health (JAGX) United States $0.003B 0.00
Qualigen Therapeutics (QLGN) United States $0.003B 0.00
Heatwurx (PCSA) United States $0.002B 0.00
Conduit Pharmaceuticals (CDT) United States $0.002B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.002B 0.00
TNF Pharmaceuticals (TNFA) United States $0.002B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.002B 0.00
Universe Pharmaceuticals INC (UPC) China $0.000B 0.00
Indivior (INDV) United States $0.000B 8.62
4D Pharma (LBPS) United Kingdom $0.000B 0.00
MEI Pharma (MEIP) United States $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Silence Therapeutics (SLN) United Kingdom $0.000B 0.00